Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Vultaggio

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|January 17, 2020
Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reactionAlessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 28, 2026
Efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literaturePietro Orlando, Letizia Flammia, Emanuele Vivarelli, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 1, 2023
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary reportPietro Orlando, Giuseppe Licci, Donald Kuitche, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 5, 2021
Effect of dupilumab treatment in a severe asthma patient with EGPAAndrea Matucci, Susanna Bormioli, Luisa Bercich, et al.
Expert Opinion on Drug Safety|May 25, 2016
The safety of monoclonal antibodies in asthmaGiovanni Passalacqua, Andrea Matucci, Alessandra Vultaggio, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 25, 2022
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma controlEmanuele Vivarelli, Andrea Matucci, Paola Parronchi, et al.
Clinical and Experimental Immunology|June 1, 2021
Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experienceEmanuele Vivarelli, Andrea Matucci, Susanna Bormioli, et al.
Scientific Reports|June 16, 2021
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxisAlessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2017
IL-10-Producing Infliximab-Specific T Cells Regulate the Antidrug T Cell Response in Exposed PatientsAlessandra Vultaggio, Francesca Nencini, Sara Pratesi, et al.
The Journal of International Medical Research|September 30, 2016
How the immune system responds to therapeutic biological agentsAlessandra Vultaggio, Giulia Petroni, Sara Pratesi, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Allergy and Clinical Immunology. in Practice|January 17, 2020
Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reactionAlessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 28, 2026
Efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literaturePietro Orlando, Letizia Flammia, Emanuele Vivarelli, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 1, 2023
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary reportPietro Orlando, Giuseppe Licci, Donald Kuitche, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 5, 2021
Effect of dupilumab treatment in a severe asthma patient with EGPAAndrea Matucci, Susanna Bormioli, Luisa Bercich, et al.
Expert Opinion on Drug Safety|May 25, 2016
The safety of monoclonal antibodies in asthmaGiovanni Passalacqua, Andrea Matucci, Alessandra Vultaggio, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 25, 2022
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma controlEmanuele Vivarelli, Andrea Matucci, Paola Parronchi, et al.
Clinical and Experimental Immunology|June 1, 2021
Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experienceEmanuele Vivarelli, Andrea Matucci, Susanna Bormioli, et al.
Scientific Reports|June 16, 2021
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxisAlessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2017
IL-10-Producing Infliximab-Specific T Cells Regulate the Antidrug T Cell Response in Exposed PatientsAlessandra Vultaggio, Francesca Nencini, Sara Pratesi, et al.
The Journal of International Medical Research|September 30, 2016
How the immune system responds to therapeutic biological agentsAlessandra Vultaggio, Giulia Petroni, Sara Pratesi, et al.
Pageof 14